mardi 13 mars 2018

Onco Actu du 13 mars 2018

2.11 Etiologie - Alimentation

What We Know About Coffee And Cancer -- California and IARC, Take Note [Forbes]

2.5 Etiologie - Gènes

Scientists find treasure trove of 110 genes linked to breast cancer [Institute of Cancer Research]

3.1 Prévention - Tabac

Global Health: In Poor Countries, Antismoking Activists Face Threats and Violence [NY Times]

4.1 Dép., diag. & prono. - Prostate

Study Finds Shared Decision Making Still Lacking in Prostate Cancer Screening [ACS]

4.12 Biopsies liquides

Can Liquid Biopsies Compete with Scopes and Scans in Cancer Diagnosis? [DNA Science]

5. Traitements

Science Surgery: ‘What’s being done to use treatments in different types of cancer?’ [Cancer Research UK]

5.1 Traitements - Pré-clinique

Aggressive breast cancer can be transformed into a treatable form [Karolinska Institutet]

Scientists discover exciting new line of attack for hard-to-treat breast cancers [Institute of Cancer Research]

Drug May Help Prevent Resistance to Toxin-Based Leukemia Therapy [NCI]

5.12.4 Immunothérapies - Essais

Advaxis Reports Fiscal 2018 First Quarter Financial Results And Announces Clinical Hold In Axalimogene Filolisbac Phase 1/2 Combination Study With AstraZeneca’s IMFINZI® (Durvalumab) [Advaxis]

Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge [EndPoints]

5.12.6 Immunothérapies - AMM

BMS’s Farajallah: Opdivo is the only PD-1 inhibitor approved for four-week dosing [The Cancer Letter]

5.12.8 Immunothérapies - Economie

NICE minded to reject Keytruda for classical Hodgkin lymphoma [PharmaTimes]

5.3.4 Traitements - AMM (FDA, EMA,...)

Beyond morphology: FDA mulls acute lymphoblastic leukemia drug based on elimination of “minimal residual disease” [The Cancer Letter]

5.4 Traitements - Economie

America’s “NICE”? [Health Affairs]

6.10.1 Politiques (USA)

The cruel sham that is “right-to-try” will be up for a vote in the House tomorrow [Respectful Insolence]

6.3 Associations/Fondations

Despite Pharma Ties, Some Patient Groups Protest High Drug Prices [Xconomy]

6.5 Médecines alternatives

NHS homeopathy ending in London [BBC News]

6.7 DMP, Big Data & applis

AI researchers embrace Bitcoin technology to share medical data [Nature]

6.7.1 Bioinformatique

Images of Machine Learning [In the Pipeline]

Math models for medical decision-making: a double-edged sword [Cancer World]

6.9 Controverses

'Shameful': widespread outrage over man denied NHS cancer care [The Guardian]